97 related articles for article (PubMed ID: 2190182)
21. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
22. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
23. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
24. [Detection of the Mbcr/abl translocation using FISH in bone marrow samples from patients diagnosed with CML and ALL].
Vargas MT; Fernández-Novoa MC; García-Creus MD; González-Ruano J
Sangre (Barc); 1996 Oct; 41(5):399-400. PubMed ID: 9026927
[No Abstract] [Full Text] [Related]
25. [Diagnosis and follow-up in chronic myeloid leukemia. Detection and quantification of specific transcripts with the help of reverse transcriptase-polymerase chain reaction].
Osland A; Shammas FV; Heikkilä R
Tidsskr Nor Laegeforen; 1996 Feb; 116(6):726-30. PubMed ID: 8644073
[TBL] [Abstract][Full Text] [Related]
26. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
27. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of Bcr-Abl-induced oncogenesis.
Gishizky ML
Cytokines Mol Ther; 1996 Dec; 2(4):251-61. PubMed ID: 9384712
[TBL] [Abstract][Full Text] [Related]
29. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
30. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
31. Transposition of the abl proto-oncogene in Philadelphia--negative chronic myeloid leukaemia and acute lymphocytic leukaemia.
Stopera SA; Davie JR; Ray M
Cytobios; 1990; 61(246-247):161-70. PubMed ID: 2163816
[TBL] [Abstract][Full Text] [Related]
32. The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.
Van Etten RA
Cancer Treat Res; 1993; 64():295-325. PubMed ID: 8095796
[No Abstract] [Full Text] [Related]
33. Myeloid antigen positive acute lymphoblastic leukemia with the Philadelphia translocation and a jumping translocation of 1q in a child.
Montgomery KD; Winter SS; Frost JD; Hardekopf D; Holt K; Graham ML; Foucar K
Leukemia; 2004 Sep; 18(9):1548-50. PubMed ID: 15284862
[No Abstract] [Full Text] [Related]
34. Long-range mapping of the normal BCR gene.
Gao LM; Goldman J
Leukemia; 1991 Jul; 5(7):555-60. PubMed ID: 1649356
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic advances in chronic myelogenous leukemia.
Epner DE; Koeffler HP
Ann Intern Med; 1990 Jul; 113(1):3-6. PubMed ID: 2073245
[No Abstract] [Full Text] [Related]
36. Molecular and cytogenetic studies of a patient with Philadelphia-negative, BCR-positive chronic myeloid leukemia and t(12;12)(q13;p12).
Zaccaria A; Testoni N; Tassinari A; Celso B; Emanuel BS; Budarf M; Saglio G; Guerrasio A; Barletta C; Peschle C
Genes Chromosomes Cancer; 1990 Mar; 1(4):284-8. PubMed ID: 2278960
[TBL] [Abstract][Full Text] [Related]
37. Identification of chromosomal breakpoints of cancer-specific translocations by rolling circle amplification and long-distance inverse PCR.
Thorsen J; Micci F; Heim S
Cancer Genet; 2011 Aug; 204(8):458-61. PubMed ID: 21962896
[TBL] [Abstract][Full Text] [Related]
38. [Molecular biology of chronic myeloid leukemia].
Rodríguez CM
Rev Fac Cien Med Univ Nac Cordoba; 1996; 54(1-2):39-46. PubMed ID: 9336062
[No Abstract] [Full Text] [Related]
39. [Chronic myeloid leukemia: from cytogenetics to molecular biology].
Aissaoui Z; Lai J; Fenaux P; Kerckaert JP
Rev Med Interne; 1990; 11(4):308-12. PubMed ID: 2096436
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic peculiarities in chronic myelogenous leukemia.
Hild F; Fonatsch C
Cancer Genet Cytogenet; 1990 Jul; 47(2):197-217. PubMed ID: 2357695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
